Zobrazeno 1 - 10
of 163
pro vyhledávání: '"quality-adjusted life years (QALY)"'
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-17 (2024)
Abstract Background Multiple sclerosis (MS) is a chronic and progressive neurological autoimmune disease that affects the central nervous system. There are two types of drugs used to treat this disease: injectable and oral drugs. The present study ai
Externí odkaz:
https://doaj.org/article/1c2ecac905344a7792d378a1bbe51294
Autor:
Mickaël Hiligsmann, Olivier Bruyère
Publikováno v:
Global & Regional Health Technology Assessment, Vol 11, Iss 1 (2024)
Osteoarthritis (OA) is a degenerative joint disease with a substantial global burden, causing chronic pain and reduced quality of life. Managing OA efficiently while maximizing healthcare resources is crucial. Health economics and health technology a
Externí odkaz:
https://doaj.org/article/73fb43b3fcf74f9a9f0b5a50ca1f3669
Autor:
Alexei Alexeevich Romanyukha, Konstantin Alexandrovich Novikov, Konstantin Konstantinovich Avilov, Timofey Alexandrovich Nestik, Tatiana Evgenevna Sannikova
Publikováno v:
Infectious Disease Modelling, Vol 8, Iss 2, Pp 403-414 (2023)
Background: During the COVID-19 pandemic, many countries used lockdowns as a containment measure. While lockdowns successfully contributed to slowing down the contagion, the related mobility restrictions were reportedly associated with an increased r
Externí odkaz:
https://doaj.org/article/0e8113f8c4dd47c2946704f470148b40
Publikováno v:
Health and Quality of Life Outcomes, Vol 21, Iss 1, Pp 1-14 (2023)
Abstract Background Preference heterogeneity in health valuation has become a topic of greater discussion among health technology assessment agencies. To better understand heterogeneity within a national population, valuation studies may identify lat
Externí odkaz:
https://doaj.org/article/df1f589a116b4cb989181cfaee5bdc2a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Фармакоэкономика, Vol 13, Iss 4, Pp 367-376 (2021)
Introduction. Presently, the willingness-to-pay threshold (cost-effectiveness threshold, incremental cost-effectiveness ratio) is used as one of the decision-making criteria for reimbursement in some foreign countries with a developed system of healt
Externí odkaz:
https://doaj.org/article/5134d26ead4649258bfe6bbe8ba84fe1
Autor:
Shalin Rawal, Kamal Sharma, Aditya Shah, Shriya Bavishi, Cleris Christian, Parjanya Bhatt, Ashwati Konat
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Externí odkaz:
https://doaj.org/article/e7ac2725810644059abd35b52b0912e7
Autor:
Aznida Firzah Abdul Aziz, Nor Azlin Mohd Nordin, Amrizal Muhd Nur, Saperi Sulong, Syed Mohamed Aljunid
Publikováno v:
BMC Geriatrics, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background The delivery of post stroke care is fragmented even in advanced public healthcare systems, globally. Primary care teams are entrusted to provide longer term care for stroke survivors in most developing countries. The integrated Ca
Externí odkaz:
https://doaj.org/article/b82c0cc9baba4d6fa29295ce6aa3853c
Autor:
Luiza M Neves, Lorena M Haefeli, Andrea A Zin, Ricardo E Steffen, Zilton F. M Vasconcelos, Márcia Pinto
Publikováno v:
Frontiers in Pediatrics, Vol 9 (2021)
Purpose: To evaluate the cost–utility of wide-field imaging (WFI) as a complementary technology for retinopathy of prematurity (ROP) screening from the Brazilian Unified Health System's perspective.Introduction: ROP is one of the leading causes of
Externí odkaz:
https://doaj.org/article/f225f210c8bc404e81f4f1bce329c699